In Axcan Scandipharm v. Reed Smith, Axcan, a pharmaceutical company, claimed that the firm engaged in an impermissible conflict that led to disclosure of confidential information by the firm to a second client.
According to an opinion written by Philadelphia’s Commerce Case Management Program Judge Howland W. Abramson, Reed Smith represented Axcan in a patent litigation case brought against the company in federal court. Axcan was indemnified by American Home Products Corp. (AHP) — which is now known as Wyeth — and/or Eurand International, and AHP/Eurand paid Reed Smith for its representation of Axcan under that indemnification agreement, Abramson said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]